SCHEMBL3018922

SCHEMBL3018922

CCCCCCCCCCCCCCCCC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+]

nearest known ligand 0.56

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 2/20 0.56
CA1 known ✓ P00915 2/20 0.53
GPR84 Q9NQS5 4/20 0.47
NFKB1 P19838 2/20 0.44
FFAR1 O14842 1/20 0.41
TSHR P16473 2/20 0.41
CYP3A4 P08684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR1I2 O75469 1/20 0.41
RECQL P46063 2/20 0.40
MAPT P10636 1/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
EPHX2 P34913 1/20 0.40
TP53 P04637 1/20 0.40
BLM P54132 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2123674 1.00 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL25301056 1.00 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL459856 0.91 FABP3 (0.50) CA2CA1NPSR1RECQLMAPT
Potassium Ion SCHEMBL1094530 0.87 FABP3 (0.53) NPSR1RECQLMAPTEPHX2BLM
SCHEMBL247523 0.85 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL2123672 0.85 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL8022640 0.85 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL11699305 0.85 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL66700 0.85 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1
SCHEMBL30424973 0.85 CA2 (0.56) CA2CA1GPR84NFKB1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110754485-A Efficient slow-release low-residue bactericide for vegetables and preparation method thereof 陈永福 2020-02-07 CN claimed
CN-113143950-B Pharmaceutical composition for treating liver diseases and application thereof 河北医科大学第二医院 2023-04-18 CN disclosed
CN-112716945-B Pharmaceutical composition and application thereof 河北医科大学 2022-11-15 CN disclosed
CN-113143950-A Pharmaceutical composition for treating liver diseases and application thereof 河北医科大学第二医院 2021-07-23 CN disclosed
CN-112716945-A Pharmaceutical composition and application thereof 河北医科大学 2021-04-30 CN disclosed
CN-110754485-A Efficient slow-release low-residue bactericide for vegetables and preparation method thereof 陈永福 2020-02-07 CN disclosed
US-20140128299-A1 AMINE-FREE VOC-FREE METAL WORKING FLUID CHEMETALL GMBH (DE) 2014-05-08 US disclosed
EP-2705128-A1 AMINE-FREE VOC-FREE METAL WORKING FLUID Chemetall GmbH (DE) 2014-03-12 EP disclosed
WO-2012152639-A1 AMINE-FREE VOC-FREE METAL WORKING FLUID CHEMETALL GMBH (DE) 2012-11-15 WO disclosed
US-20100204324-A1 Optically Active N-(Alpha-Mercaptopropionyl)Glycine NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2010-08-12 US disclosed
EP-2181984-A1 AN OPTICALLY ACTIVE N- (alpha-MERCAPTOPROPIONY) GLYCINE Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) 2010-05-05 EP disclosed
US-4336307-A MELT SPINNING WITH A ORGANIC ALKALI OR ALKALINE EARTH METAL SULFONATE PORE FORMING AGENT TEIJIN LIMITED (JP) 1982-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204324-A1 Optically Active N-(Alpha-Mercaptopropionyl)Glycine GNMT, MGST1, GSTP1 CA2 3353/4885CA1 3251/4885GPR84 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.